ArticleJournal of translational medicine2023

B7H3-targeting chimeric antigen receptor modification enhances antitumor effect of Vγ9Vδ2 T cells in glioblastoma.

Yi Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.